Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

Market Cap	11.31B
Revenue (ttm)	3.21B
Net Income (ttm)	326.41M
Shares Out	455.75M
EPS (ttm)	0.71
PE Ratio	34.89
Forward PE	25.66
Dividend	0.30 (1.16%)
Ex-Dividend Date	May 21, 2025

Volume	17,665,544
Average Volume	18,357,367
Open	24.85
Previous Close	25.91
Day's Range	24.70 - 25.88
52-Week Range	11.25 - 28.90
Beta	0.54
RSI	63.81
Earnings Date	Aug 25, 2025

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products. The company offers anthelmintics, pet vaccines, ear canal treatment drugs, anesthetic analgesics, antibiotics, antivirals, various internal medicine drugs, as well as disinfectant products, including compound potassium peroxymonosulphate, deciquam solution, and glutaral solution, API products, herbal medicines, and cleaning agents for poultry...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,900
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300119

Financial Performance

In 2024, SHE:300119's revenue was 3.07 billion, an increase of 13.32% compared to the previous year's 2.71 billion. Earnings were 300.72 million, a decrease of -33.70%.